Prospective, non-interventional study on the influence of adherence measures on the therapy with abiraterone acetate (AA) + prednisone/prednisolone (P) in patients with metastatic, castration resistant prostate carcinoma.

Henrik Suttmann,Susan Feyerabend,Jochen Gleissner,Andreas Huebner,Edmund Neugebauer,Tim Mathes,Werner Baurecht,Natasha Schuier

Prospective, non-interventional study on the influence of adherence measures on the therapy with abiraterone acetate (AA) + prednisone/prednisolone (P) in patients with metastatic, castration resistant prostate carcinoma.

2016

Henrik Suttmann
Susan Feyerabend
Jochen Gleissner
Andreas Huebner
Edmund Neugebauer
Tim Mathes
Werner Baurecht
Natasha Schuier

e16525Background: AA is a blocker of androgen biosynthesis, which is highly effective in men with mCRPC in prolonging PFS and OS. Oncology experiences an increase in oral cancer drugs treatments, f...

Keywords:

Urology
Prednisolone
Abiraterone acetate
Pathology
Castration-Resistant Prostate Carcinoma
Prednisone
Medicine
non interventional
in patient
Androgen biosynthesis
Oncology
cancer drugs
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations